1 Year Total Returns (Daily) Chart

View 1 Year Total Returns (Daily) for OVID.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View 1 Year Total Returns (Daily) Chart
Start Trial

Historical 1 Year Total Returns (Daily) Data

View and export this data back to 2018. Start Trial.
Date Value
September 25, 2026 70.21%
September 24, 2026 78.21%
September 23, 2026 104.0%
September 22, 2026 114.0%
September 21, 2026 124.0%
September 18, 2026 120.5%
September 17, 2026 132.8%
September 16, 2026 135.1%
September 15, 2026 111.7%
September 14, 2026 117.5%
September 11, 2026 115.2%
September 10, 2026 110.4%
September 09, 2026 117.7%
September 08, 2026 121.8%
September 04, 2026 117.1%
September 03, 2026 109.0%
September 02, 2026 120.3%
September 01, 2026 115.6%
August 31, 2026 108.6%
August 28, 2026 124.0%
August 27, 2026 132.5%
August 26, 2026 136.1%
August 25, 2026 155.3%
August 24, 2026 173.8%
August 21, 2026 192.6%
Date Value
August 20, 2026 188.4%
August 19, 2026 211.7%
August 18, 2026 204.5%
August 17, 2026 197.9%
August 14, 2026 236.8%
August 13, 2026 226.3%
August 12, 2026 379.0%
August 11, 2026 364.3%
August 10, 2026 408.8%
August 07, 2026 414.2%
August 06, 2026 419.4%
August 05, 2026 427.9%
August 04, 2026 411.6%
August 03, 2026 366.0%
July 31, 2026 344.0%
July 30, 2026 374.0%
July 29, 2026 323.8%
July 28, 2026 347.4%
July 27, 2026 280.0%
July 24, 2026 236.2%
July 23, 2026 242.9%
July 22, 2026 255.8%
July 21, 2026 298.1%
July 20, 2026 319.1%
July 17, 2026 409.1%

Total Return Definition

The Total return is the change in price over a specific period of time that includes dividends and distributions paid.

Read full definition.

1 Year Total Returns (Daily) Range, Past 5 Years

View 1 Year Total Returns (Daily) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

1 Year Total Returns (Daily) Benchmarks

View 1 Year Total Returns (Daily) Benchmarks
Start Trial
ACADIA Pharmaceuticals, Inc. -2.50%
Alnylam Pharmaceuticals, Inc. -43.07%
Anika Therapeutics, Inc. 126.3%
Savara, Inc. 44.09%
Vericel Corp. 33.08%